Eikon Therapeutics (NASDAQ: EIKN) has announced FDA clearance of its Investigational New Drug (IND) application for EIK1006, a novel androgen receptor antagonist, paving the way for its first-in-human Phase 1/2 study in...
MedMira (TSXV: MIR) has announced that the FDA has granted Breakthrough Device Designation to its Multiplo Complete Syphilis (TP/nTP) Antibody Test. According to MedMira, unlike conventional laboratory-based testing...
Therapists and other healthcare professionals often work in settings where they may be alone with patients, make home visits or conduct sessions outside traditional clinical environments. Yet, despite the potential for...
Allarity Therapeutics (NASDAQ: ALLR) has confirmed expanded eligibility for its ongoing Phase 2 stenoparib trial in advanced ovarian cancer, opening the study to patients with primary platinum-refractory disease and...
Lexeo Therapeutics (NASDAQ: LXEO) has announced positive interim data from the ongoing HEROIC-PKP2 Phase 1/2 clinical trial of LX2020 for the treatment of PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). According to...
Helus Pharma (NASDAQ: HELP; Cboe CA: HELP) has announced positive topline results from APPROACH, its Phase 3 pivotal study evaluating HLP003 (deuterated psilocin), as an adjunctive treatment for adults with major...
Cardiff Oncology (NASDAQ: CRDF) has announced that the FDA has granted Fast Track designation to onvansertib in combination with FOLFIRI/bevacizumab for the first-line treatment of adult patients with KRAS- or NRAS...
DBV Technologies (Euronext: DBV; ISIN: FR0010417345; NASDAQ: DBVT) has announced that three presentations at the American College of Allergy, Asthma & Immunology (ACAAI) 2026 Annual Scientific Meeting in Phoenix...
Moleculin Biotech (NASDAQ: MBRX) has announced an Australian patent covering the preparation of preliposomal Annamycin lyophilizate, strengthening its intellectual property protection for the formulation technology...
Acute Care Alberta is leveraging top wound care products and technologies to treat the 21 soldiers who remain hospitalized in Alberta following the CFB Wainwright grass fire on October 17, 2026, including AVITA...